PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 6.81

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-15 )

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.08% 51% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.08% 49% F 33% F
Trailing 12 Months  
Capital Gain -13.80% 31% F 18% F
Dividend Return 0.99% 52% F 17% F
Total Return -12.81% 30% F 16% F
Trailing 5 Years  
Capital Gain -32.71% 12% F 9% A-
Dividend Return 2.77% 16% F 5% F
Total Return -29.94% 9% A- 7% C-
Average Annual (5 Year Horizon)  
Capital Gain 56.65% 79% B- 95% A
Dividend Return 57.24% 79% B- 94% A
Total Return 0.60% 41% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 393.04% 15% F 3% F
Risk Adjusted Return 14.56% 27% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.